Improvement of a commercial calcium phosphate bone cement by means of drug delivery and increased injectability
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries
2. Bone substitutes in orthopaedic surgery: from basic science to clinical practice10.1007/s10856-014-5240-2 ↗
3. A new calcium phosphate setting cement
4. Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties10.1016/j.actbio.2013.11.001 ↗
5. Calcium phosphate cements for bone engineering and their biological properties10.1038/boneres.2017.56 ↗
6. Calcium phosphate bone cements10.1533/9781845695170.2.206 ↗
7. Biological and mechanical performance and degradation characteristics of calcium phosphate cements in large animals and humans10.1016/j.actbio.2020.09.031 ↗
8. Critical review: injectability of calcium phosphate pastes and cements10.1016/j.actbio.2016.11.019 ↗
9. Local antibiotic delivery systems for the treatment of osteomyelitis - a review10.1016/j.msec.2009.07.014 ↗
10. Osteomyelitis: an overview of antimicrobial therapy10.1590/S1984-82502013000100003 ↗
11. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis10.1517/17425247.2013.751371 ↗
12. Calcium phosphate cements as drug delivery materials10.1016/j.addr.2012.01.008 ↗
13. Webb · 2018 · 15
14. Ceramed, Neocement, (2020) 1–2.
15. The influence of different cellulose ethers on both the handling and mechanical properties of calcium phosphate cements for bone substitution10.1016/j.actbio.2012.11.020 ↗
16. 2008 · 1
17. Standard specification for acrylic bone cement; ASTM F 451-08
18. A validated quantitative colorimetric assay for gentamicin10.1016/S0731-7085(99)00192-2 ↗
19. 2012 · 1
20. Rheological properties of concentrated aqueous injectable calcium phosphate cement slurry10.1016/j.biomaterials.2006.05.043 ↗
21. Limited compliance of some apatitic calcium phosphate bone cements with clinical requirements10.1023/A:1008939710282 ↗
22. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair10.1016/j.actbio.2010.07.012 ↗
23. Mechanisms underlying the limited injectability of hydraulic calcium phosphate paste10.1016/j.actbio.2008.03.004 ↗
24. Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate10.1002/jbm.b.30403 ↗
25. In vitro elution of gentamicin, amikacin, and ceftiofur from polymethylmethacrylate and hydroxyapatite cement10.1053/jvet.2000.7535 ↗
26. H.. Busscher, Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release10.1016/S0142-9612(00)00082-X ↗
27. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile
28. Polymeric additives to enhance the functional properties of calcium phosphate cements10.1177/2041731412439555 ↗
29. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system10.1021/js960405a ↗
30. Gamma sterilization of pharmaceuticals - a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations10.5731/pdajpst.2014.00955 ↗
31. Controlled release of gentamicin from calcium phosphate/alginate bone cement10.1016/j.msec.2010.10.002 ↗
32. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement10.1016/j.biomaterials.2006.03.032 ↗
33. The role of alkaline phosphatase in osteogenesis10.1084/jem.93.5.415 ↗
34. Chitosan/hydroxyapatite (HA)/hydroxypropylmethyl cellulose (HPMC) spongy scaffolds-synthesis and evaluation as potential alveolar bone substitutes10.1016/j.colsurfb.2017.09.059 ↗
35. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo10.1016/j.biomaterials.2003.10.083 ↗
36. Ready-to-use injectable calcium phosphate bone cement paste as drug carrier10.1016/j.actbio.2013.08.009 ↗
37. Self-setting calcium orthophosphate formulations10.3390/jfb4040209 ↗
38. Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials10.1016/S0142-9612(01)00221-6 ↗
39. Rey · 2011
40. The FTIR spectroscopy and QXRD studies of calcium phosphate based materials produced from the powder precursors with different Ca/P ratios10.1016/S0272-8842(96)00016-8 ↗
41. Apatite formation: why it may not work as planned, and how to conclusively identify apatite compounds10.1155/2013/490946 ↗
42. Basic properties of calcium phosphate cement containing different concentrations of citric acid solution
43. A new calcium phosphate, water-setting cement
44. A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis, Evidence-Based Complement
45. High-viscosity cement significantly enhances uniformity of cement filling in vertebroplasty: an experimental model and study on cement leakage10.1097/01.brs.0000240695.58651.62 ↗